AMERICAN SHARED HOSPITAL SERVICES Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 50.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2025-04-04
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2024 was 50.00%, a 0.00% change from fiscal 2023.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2023 was 50.00%, a 0.00% change from fiscal 2022.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 50.00%, a 25.00% increase from fiscal 2021.
- AMERICAN SHARED HOSPITAL SERVICES share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2021 was 40.00%, a 0.00% change from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|
| 2024-12-31 | 50.00% 10-K · filed 2025-04-04 |
| 2023-12-31 | 50.00% 10-K · filed 2024-04-01 |
| 2022-12-31 | 50.00% 10-K · filed 2024-04-01 |
| 2021-12-31 | 40.00% 10-K · filed 2023-03-31 |
| 2020-12-31 | 40.00% 10-K · filed 2022-03-30 |
| 2019-12-31 | 50.00% 10-K · filed 2021-04-06 |
| 2018-12-31 | 50.00% 10-K · filed 2020-04-03 |
| 2017-12-31 | 53.00% 10-K · filed 2020-04-03 |
| 2016-12-31 | 53.00% 10-K · filed 2019-03-29 |
| 2015-12-31 | 41.00% 10-K · filed 2018-03-28 |
| 2014-12-31 | 40.00% 10-K · filed 2017-03-27 |
| 2013-12-31 | 49.00% 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |